Abstract：Objective: To investigate the ultrasonic features and clinicopathologic characteristics of the triple negative breast cancer(TNBC) and non-triple negative breast cancer(NTNBC)． Methods: Forty-six TNBC and 50 NTNBC cases were analyzed retrospectively, to compare the difference of ultrasonograms and clinicopathologic features. Results: The average age of TNBC group was 48.49±11.66 years old, the mean size of tumors was (4.69±3.78) cm, and the sign of lobular tumor edge frequently occurred(P<0.01). The average age of NTNBC group was 46.83±9.12 years old, the mean size of tumors was (2.61±0.91) cm. In the NTNBC group, the signs of spiculation(P＜0.01), micro-calcification(P<0.01) and posterior echo attenuation(P<0.05) showed statistically significant difference. There was no statistically significant difference in axillary lymph node metastasis rate. Conclusion: The features of ultrasonograms and clinicopathology were different between NTNBC and TNBC, which had their own characteristics.
贾志莺，张银华，冷晓玲，马富成. 三阴性及非三阴性乳腺癌超声、临床病理特征的回顾性分析[J]. 中国临床医学影像杂志, 2017, 28(1): 23-26.
JIA Zhi-ying, ZHANG Yin-hua, LENG Xiao-ling, MA Fu-cheng. Retrospective analysis on ultrasonic and clinicopathologic features of triple and#br# non-triple negative breast cancer. JOURNAL OF CHINA MEDICAL IMAGING, 2017, 28(1): 23-26.
[1]雷蕾，王晓稼，杨红健，等. 乳腺癌分子分型在新辅助化疗疗效和预后中的预测作用[J]. 中国肿瘤，2012，21（11）：868-873.
[2]Berry DA, Cirrincionf C, Henderson IC, et al． Estrogen-receptor status and outcomes of modern chemotherapy for patient with node-positive breast cancer[J]. JAMA, 2006, 295(14): 1658－1667．
[3]Adler DD, Carson PL, Rubin JM, et al. Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings[J]. Ultrasound Med Biol, 1990, 16(6): 553-559．
[4]Reis-Filho JS, Tutt AN. Triple negative tumours: a critical review[J]. Histopathology, 2008, 52(1): 108-118.
[5]关印，徐兵河. 三阴性乳腺癌的临床病理特征及预后分析[J]. 中华肿瘤杂志，2008，30（3）：196-199.
[6]欧江华，蒋威华，倪多，等. 新疆地区三阴性乳腺癌临床特征及预后分析[J]. 中国肿瘤临床，2011，38（18）：1159-1162.
[7]吉茹，李敬永，赵秀兰，等. 三阴性乳腺癌临床病理特点及与EGFR表达关系的探讨[J]. 中国肿瘤临床，2010，37（1）：32-35.
[8]Kurosumi M. Significance of immunohistochemical assessment of steroid hormone receptor status for breast cancer patients[J]. Breast Cancer, 2003, 10(2): 97-104.
[9]Yingbing W, Debra M, Ikeda MD, et al. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without man epidermal growth factor receptor type 2 over expression[J]. Radiology, 2008, 246(2): 367-375.
[10]Mancini P, Angeloni A, Risi E, et al. Standard of care and promising new agents for triple negative metastatic breast cancer[J]． Cancers(Basel), 2014, 6(4): 2187-2223.
[11]Uematsu T, Kasami M, Yuen S. Triple negative breast cancer correlation between MR imaging and pathologic findings[J]. Radiology, 2009, 250(3): 638-647．
[12]洪少馥，李颖嘉，王冬晓,等. 40岁以下青年乳腺癌超声表现与分子亚型的关系[J]. 中国医学影像技术，2015，31（7）：1028-1032.
[13]王志萍. 乳腺癌超声诊断与雌激素受体表达间的关系[J]. 肿瘤研究与临床，2007，19（5）：328-330.
[14]Ko ES, Lee BH, Kim HA, et al. Triple-negative breast cancer: correlation between imaging and pathological findings[J]. Eur Radiol, 2010, 20(5): 1111-1117.
[15]张庆慧，徐嘉雯． 提高对基底细胞样乳腺癌和三阴性乳腺癌的认识[J]. 临床与实验病理学杂志，2008，24（2）：131-136．
[16]李银珍，黄道中，张青萍，等. 乳腺浸润性导管癌超声征象与雌激素受体表达的相关性初探[J]. 中华超声影像学，2005，1（7）：449-451.
[17]陈敏，李俊来，宋丹绯，等. 乳腺浸润性导管癌雌、孕激素受体及人类上皮生长因子受体表达与超声特征的关系[J]. 中华超声影像学杂志，2008，17（4）：333-335.
[18]Carey LA, Dees EC, Sawyer L, et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes[J]. Clin Cancer Res, 2007, 13(8): 2329-2334.
2017, Vol. 28 
